Machine Learning in Biotechnology: A Working Reference Machine learning, at its core, is just a branch of artificial intelligence where a system gets better at a task by being shown examples, rather than by someone writing out every rule in advance. Biotechnology, meanwhile, is the practice of putting living systems cells, enzymes, entire organisms to work solving practical problems. Put the two together and you get something like this: algorithms trained on genomic sequences, protein structures, metabolic profiles, and imaging data, being used to speed up decisions that used to take a postdoc several years of bench work to arrive at. That's the short version. The longer version is messier, and worth sitting with for a moment. Biological data doesn't behave like the clean, well-labeled datasets that made image recognition and language models possible. It's noisy, it's expensive to generate, and a single experiment might produce more dimensions than there are sample...
Which Country Is No. 1 in Biotechnology? Ask almost any life sciences researcher, venture capitalist, or policy analyst which country leads in biotechnology, and you will get the same answer: the United States. It is not a particularly close contest. By most measures that actually matter — the volume and quality of research output, private capital deployment, the number of commercially successful companies, FDA-approved biologics, and Nobel laureates in the life sciences — the U.S. has held a commanding position for the better part of five decades. That said, "dominance" is not the same as "inevitability ." The global biotech landscape has shifted noticeably in the past fifteen years, and anyone who dismisses China's rise or underestimates the quiet productivity of Switzerland and the UK is probably not paying close enough attention. The United States as the Leading Country in Biotechnology The U.S. appears to account for somewhere between 45 and 50 percen...